Robinson+Cole Represents TradeUP Acquisition Corp. in Complex DeSPAC Transaction with Estrella Biopharma, Inc.

Robinson+Cole is pleased to announce that it has represented TradeUP Acquisition Corp. (UPTD) in the closing of its business combination with Estrella Biopharma, Inc., a preclinical-stage biopharmaceutical company developing T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. The transaction, valuing the post-combination combined entity at $325 million, was announced on October 3, 2022, and was closed on September 29, 2023. The combined public company, Estrella Immunopharma, Inc. (Nasdaq: ESLA), will commence trading on the Nasdaq Capital Market on Monday, October 2, 2023.

The team advising on the transaction, led by Arila E. Zhou, included Capital Market + Securities Team members Yang Xu, Tiange (Tim) Chen, Yi (Tiffany) Liu and Samuel C. Maduabueke. The cross-disciplinary team was also supported by Business Transactions Group lawyer Kiernan L. Ignacio, Transactional Health Law Group co-chair Leslie J. Levinson, Intellectual Property + Technology Group co-chair John L. Cordani and Intellectual Property + Technology Group partner Kathleen M. Porter. Read more.

Capital Markets + Securities Team Represents Bukit Jalil Global Acquisition 1 Ltd. in IPO

Robinson+Cole’s Capital Markets + Securities Team (the Team) was pleased to represent Bukit Jalil Global Acquisition 1 Ltd. (Bukit Jalil), a special purpose acquisition corporation incorporated in the Cayman Islands, in its recent initial public offering. On June 30, 2023, Bukit Jalil completed its $57.5 million IPO of 5,750,000 units at $10 per unit (including units sold upon the full exercise of the underwriters’ over-allotment option). The units began trading on the Nasdaq Capital Market under the ticker symbol “BUJAU” on June 28, 2023. The Team advising on the offering was led by Team Chair, Arila Zhou, and included Yang Xu and Zhe (Emmett) Tan. Read more.

Capital Markets + Securities Team Represents Hongli Group Inc. in IPO

Robinson+Cole’s Capital Markets + Securities Team (the Team) was pleased to represent Hongli Group Inc. (Hongli) in its recent initial public offering. Hongli is a holding company that, through a series of contractual arrangements, consolidates the financial results of Shandong Hongli Special Section Tube Co., Ltd. and its subsidiaries, which is one of the leading cold roll formed steel profile manufacturers in China with respect to function innovation, performance improvement, and customized manufacturing of products, according to China Sub-Association for Cold Formed Steel Industries. On March 31, 2023, Hongli completed its $8.25 million IPO of 2,062,500 ordinary shares at $4.00 per share. The ordinary shares began trading on the Nasdaq Capital Market under the ticker symbol “HLP” on March 29, 2023. The Team members advising on this offering were Arila Zhou, Anna Jinhua Wang, and Yang Xu. Read more.

Capital Markets + Securities Team Represents ICZOOM Group Inc. in IPO

Robinson+Cole’s Capital Markets + Securities Team (the Team) was pleased to represent ICZOOM Group Inc. (ICZOOM), a company engaged in sales of electronic component products to customers in Hong Kong and mainland China through its B2B e-commerce trading platform, in its recent initial public offering. On March 17, 2023, ICZOOM completed its $6 million IPO of 1,500,000 Class A ordinary shares at $4.00 per share. The Class A ordinary shares began trading on the Nasdaq Capital Market under the ticker symbol “IZM” on March 15, 2023. The Team advising on this offering were Arila Zhou, Anna Jinhua Wang, Yang Xu, Emmett Tan and Eve Mao. Read more.

Capital Markets + Securities Team Represents Horizon Space Acquisition I Corp. in IPO

Robinson+Cole’s Capital Markets + Securities Team (the Team) was pleased to represent Horizon Space Acquisition I Corp. (Horizon Space), a special-purpose acquisition corporation incorporated in the Cayman Islands, in its recent initial public offering. On December 27, 2022, Horizon Space completed its $69 million IPO of 6,900,000 units at $10 per unit (including units sold upon the full exercise of the underwriters’ over-allotment option). The units began trading on the Nasdaq Global Market under the ticker symbol “HSPOU” on December 22, 2022. The Team advising on the offering was led by Team Chair, Arila Zhou, and included Yang Xu and Zhe (Emmett) Tan. Read more here.

Capital Markets + Securities Team Pleased to Represent Feutune Light Acquisition Corporation in IPO

Robinson+Cole’s Capital Markets + Securities Team (the Team) represented Feutune Light Acquisition Corporation, a newly organized blank check company, in completing its initial public offering on June 21, 2022 of 9,775,00 units at an offering price of $10.00 per unit, which includes 1,225,000 units issued pursuant to the full exercise of the underwriter’s over-allotment option, for aggregate gross proceeds to the Company of $97.75M. The units began trading on the Nasdaq Global Market under the ticker symbol “FLFVU” on June 16, 2022. The Team members advising on the offering were Arila Zhou, Tim Chen, Christopher Homsy, Yang Xu and Samuel Maduabueke. Read more.

Capital Markets + Securities Team Pleased to Represent Prime Number Capital LLC in IPO of Phoenix Motor Inc.

Robinson+Cole’s Capital Markets + Securities Team (the Team) represented Prime Number Capital LLC, the lead underwriter in an initial public offering of Phoenix Motor Inc., a California based company that designs, assembles, and integrates electric drive systems and light and medium duty electric vehicles, of 2.1 million shares of common stock at an offering price of $7.50 per share, for aggregate gross proceeds of $15.75 million. The shares began trading on the Nasdaq Capital Market under the ticker symbol “PEV” on June 8, 2022. On June 10, 2022, the Team attended the opening bell ceremony at Nasdaq MarketSite in Times Square to celebrate the listing of PEV common stock. The Team members advising Prime Number on the offering were Arila Zhou, Anna Wang, Eve Mao and Yang Xu. Read more.

Capital Markets + Securities Team Pleased to Represent Prime Number Acquisition | Corp. in IPO

Robinson+Cole’s Capital Markets + Securities Team (the Team) represented Prime Number Acquisition | Corp., a newly organized blank check company, in completing its initial public offering on May 17, 2022 of 6,450,000 units at an offering price of $10.00 per unit, which includes 450,000 units issued pursuant to the partial exercise of the underwriter’s over-allotment option, for aggregate gross proceeds to the Company of $64.5M. The units began trading on the Nasdaq Global Market under the ticker symbol “PNACU” on May 13, 2022. The Team members advising on the offering were Arila Zhou, Tim Chen and Yang Xu. Read more.

Capital Markets + Securities Team Pleased to Represent Prime Number Capital LLC in IPO of Meihua International Medical Technologies

Robinson+Cole’s Capital Markets + Securities Team (the Team) represented Prime Number Capital LLC, the lead underwriter in an initial public offering of Meihua International Medical Technologies (Nasdaq ticker symbol “MHUA”), a manufacturer and provider of disposable medical devices with operating subsidiaries in China. At the closing of the IPO on February 18, 2022, a total of 3,940,000 ordinary shares of MHUA, listed on Nasdaq Global Market, were sold at a public offering price of $10.00 per ordinary share (the "Ordinary Shares"), including 340,000 Ordinary Shares issued pursuant to the partial exercise of the underwriters' over-allotment option, for aggregate gross proceeds of $39.4 million before deducting underwriting discounts and commissions and offering expenses. The successful share sale makes MHUA the first China-based company to list in the U.S. since July 2021. The Team members advising on the offering were Arila Zhou, Mitchell Lampert, Anna Wang, Yang Xu and Eve Mao. Read more.

Capital Markets + Securities Team Pleased to Represent Blue World Acquisition Corporation in IPO

Robinson+Cole’s Capital Markets + Securities Team (the Team) was pleased to represent Blue World Acquisition Corporation (Blue World), a special purpose acquisition corporation, in its recent initial public offering. On February 2, 2022, Blue World completed its $92 million initial public offering (including units sold upon the full exercise of over-allotment option) of 9,200,000 units at $10 per unit. The Team advising on the offering was led by Team Chair, Arila Zhou, and included Yang Xu and Tiange (Tim) Chen. Read more.

Robinson+Cole Welcomes Three-Attorney Capital Markets + Securities Team

Robinson+Cole’s growth in its New York City-based Capital Markets + Securities Team was highlighted in a Law360 article published on March 4, 2022. The article, “Robinson & Cole Grows In NY With 3-Atty SPAC Team,” highlights the recent additions of partner, Arila Zhou, and associates Yang Xu and Tiange (Tim) Chen. The team handles capital markets and securities matters with an emphasis on special purpose acquisition corporation (SPAC) transactions and initial public offerings of foreign issuers, particularly from Asia. Zhou, Xu and Chen, all native Mandarin speakers fluent in English, were previously with Hunter Taubman Fischer & Li in New York.

Last month, the team represented the lead underwriter in the IPO of Meihau International Medical Technologies, a manufacturer of disposable medical devices with operating subsidiaries in China – the first such company to list in the U.S. since July 2021. Zhou said her decision to join the firm was influenced by positive feedback from clients at her previous position, noting that “Robinson+Cole provides a full-service offering, which makes things more efficient for our clients.” Read more about the team in the press release